To study cancer heterogeneity, most research has focused on molecular and genetic associations. However, the lack of properly controlled in vitro cancer models has limited our understanding of the role of heterogeneous cancer cell subpopulations in tumor progression and invasion. In this study, we present a novel in vitro breast tumor model to mimic intratumor heterogeneity in a microfluidic system capable of providing physiologically relevant tumor microenvironment for cancer cells by incorporating ECM scaffolds. With this system, we suggest that interactions between subpopulations of cancer cells with distinct characteristics promote tumor progression and invasion. This intratumor heterogeneity model will allow new insights into phenotypic event of heterogeneous cancer cell subpopulations during invasion. 
Introduction
Cancer heterogeneity, documented since the early days of cancer research (1) , is an important aspect of tumor progression and a clinically significant factor (2) . The tumor microenvironment consists of heterogeneous cell types, including not only cancer cells but also stromal cells, such as fibroblasts and vascular cells. The critical roles of stromal cells in tumor growth and invasion (prerequisite steps of metastasis) are recognized, both in vitro and in vivo (3, 4) . Heterogeneous cancer cell subpopulations with dissimilar characteristics, designated "intratumor heterogeneity", co-exist, even within a single tumor (5) .
Intratumor heterogeneity has been identified and actively investigated with technological advances in recent years, leading two emerging conceptual frameworks: clonal evolution and cancer stem cell hypothesis (1, 6) . The majority of tumors display heterogeneous characteristics. For example, tumors consist of cells with characteristically different subtypes displaying distinct molecular and gene expression patterns (7) . Phenotypic heterogeneity, including cellular morphology, drug resistance, and proliferative, invasive and metastatic potential (2, 8) , leads to failure to predict the progression patterns of metastasis and consequently to select the most suitable treatment for patients (9, 10) .
During oncogenesis, intratumor heterogeneity is caused by both genetic and non-genetic factors, such as genetic mutations and abnormal microenvironment including activated stromal cells (11) , hypoxia (12) , and remodeled extracellular matrix (ECM) (13) .
Clinical reports have revealed that intermixed cancer cell subpopulations with distinct genetic and phenotypic characteristics exist within a single tumor (14) . There is evidence to suggest subspecialization of cancer cells and their mutual support in tumor progression (7) . To date, most research involving cancer heterogeneity has focused on molecular and genetic associations (15, 16) . However, the role of heterogeneous cancer cell subpopulations in tumor progression and invasion has been overlooked due to the lack of properly controlled in vitro models. To clarify the mechanisms by which intratumor heterogeneity influences metastasis, and more specifically, how subpopulations of cancer cells within a tumor mutually interact during the invasion process, a well-controlled experimental system is required to precisely model complex cell-to-cell and cell-to-ECM interactions under welldefined heterogeneous cancer cell subpopulations. Here, we have presented a novel in vitro breast
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Integrative Biology 4 tumor model to mimic intratumor heterogeneity by constructing a microfluidic system incorporating ECM scaffolds capable of providing a physiologically relevant tumor microenvironment. To investigate the influence of subpopulations of cancer cell on invasion, we composed the intratumor heterogeneity with cancer subpopulations that have the distinct degree of invasive potential: 1) highly invasive cancer cells (HIC), MDA-MB-231, with the high invasive potential and the capacity of proteolytic ECM remodeling, and 2) Epithelial-like cancer cells (ELC), MCF-7, which retain epithelial characteristics that presents a none-aggressive and low-invasive phenotype with strong cell-cell junction. These subpopulations of cells were co-cultured in a carefully controlled microfluidic environment in contact with various ECM scaffolds. Our results suggest that interactions between HICs and ELCs promote tumor invasion with HIC acting as the leader and ELC as the follower, and therefore influence metastatic potential.
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Materials and Methods
Fabrication of the microfluidic system: A microfluidic device composed of PDMS (polydimethylsiloxane; Sylgard 184; Dow Corning, MI, USA) with four ECM scaffold regions and three main microchannels was fabricated with a SU-8 photoresist master (MicroChem, MA, USA) using a conventional soft lithography process. The PDMS-based microfluidic system was bonded onto a sterilized 24×24 cover glass using oxygen plasma (Femto Science, Korea) after autoclaving, and coated with poly-D-lysine hydrobromide (PDL, MW 30,000-70,000, Sigma-Aldrich, St Louis, MO).
Collagen type I (rat tail; cat. no. 40236; BD Bioscience) or matrigel (growth factor reduced (GFR)
Phenol Red-free; BD Bioscience) hydrogel was used as the ECM scaffold. Collagen solution was diluted to 2 mg/ml in 10X PBS and deionized water, and pH adjusted with 0.5 N NaOH to 11. ECM hydrogel was filled into and fixed in ECM scaffold regions with a micropipette, followed by incubation for 30 min at 37°C in a 5% CO 2 incubator for gelling. After gelation, all microchannels were filled with culture medium and incubated at 37°C in a 5% CO 2 incubator, prior to use. 
Functional blocking of E-cadherin with antibody:
After seeding and allowing cell attachment to the ECM scaffolds, cells were cultured in RPMI 1640 containing 1% FBS in the presence of 5 µg/ml Ecadherin monoclonal antibody (SHE78-7, Novex®), and the medium containing 5 µg/ml SHE78-7 antibody changed daily for 3 days.
Immunocytochemistry: Cell fixation and permeabilization were carried out in a similar manner as described for heterogeneous cell culture imaging before blocking. Cells were blocked with Block ACE (DS Pharma Biomedical Co., Japan) for >1 h at room temperature and washed with PBS more than twice. Thereafter, 60 µl of 1:100 diluted primary antibody solution of anti-Claudin 5 (Abcam), antiClaudin 1 (Abcam), anti-Occludin (Abcam), and E-cadherin (H-108) (Santa Cruz Biotechnology) in PBS was added to each microchannel and incubated at 4°C overnight. After washing with PBS, secondary Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+L) (Molecular Probe) was added and
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HICs extraction from ECM scaffolds: HICs invading ECM in the microfluidic system were extracted after culture for 3 days. HICs were removed from ECM by incubating with an extraction solution (0.5%
Triton X-100, 20 mM NH 4 OH in PBS) for 2 h, washed more than three times with culture medium, (17) and incubated at 37°C in a 5% CO 2 incubator overnight before use. Quantification: Cells invading ECM were counted after nuclear staining with DAPI, and the number of cells on the side of the ECM scaffold determined by dividing the size of tumor mass by single cell size. The invading distance was quantified by measuring the distance of the furthest cell from the starting point. Moreover, the index of microtracks filled by cells was analyzed by dividing the total number of generated microtracks, paths in ECM scaffold through which HICs invaded, by the number of microtracks filled by cells.
Laminin antibody staining for remodeled ECM:
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Results and Discussion
HICs induce and lead 3D invasion of ELCs into Matrigel, but not type 1 collagen
We developed an in vitro microfluidic model of heterogeneous cancer cell subpopulation culture to mimic diverse intratumoral conditions and study the invasive potentials of various subpopulations. A specific microfluidic cell culture device incorporating the ECM scaffold was constructed to provide a 
Microtracks generated by HICs in MAT promote ELC invasion
Matrix-dependent plasticity of cancer cells has been reported previously (18) . We proposed that since Our data suggest that the microtracks within MAT generated by HICs contribute to a proportion of ELC invasion, but are not sufficient to promote considerable ELC invasion.
The strong cell-cell adhesion required for epithelial maintenance in ELCs may prevent cellular invasion into microtracks. This hypothesis was examined by suppressing expression of E-cadherin, a calcium-dependent cell-cell adhesion molecule, in ELCs with a specific neutralizing antibody, SHE 78-7 (5µg/ml), and comparing the invasion of non-treated (NT) and SHE 78-7-treated ELCs into preformed microtracks. Quantification data showed significantly increased invasion of SHE 78-7-treated ELCs (Figure 4a & 4c) further along the microtracks (Figure 4b& 4c) , compared with nontreated ELCs. Without microtracks or HICs, SHE 78-7-treated ELCs remained non-invasive on the side of MAT. However, upon co-culture of SHE 78-7-treated ELCs with HICs, invasion was markedly increased relative to NT ELCs co-cultured with HICs (Figure 4d) , along with the number of invading ELCs per single HIC (Figure 4e & 4f) . These data clearly suggest that HICs promote ELC invasion, when cell-cell adhesion in ELCs is suppressed. Moreover, cell-cell adhesion in ELCs is so strong that the cells tend not to migrate along the preformed microtracks, suggesting that other factors influence ELC invasion.
Cell-cell interactions via junction proteins between HIC and ELC are required for ELC invasion
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Integrative Biology HIC appears to lead the ELC invasion via two main mechanisms: (1) Figure 3) . This results might carefully suggest that HICs would increase the cell-cell contact between ELCs and vice versa, and enhance their invasion potential by leading collective invasion, resulting in promotion of metastatic potential (Supplementary Figure 4) .
To confirm whether soluble factors secreted by HICs influence ELC invasion in addition to physical contact, ELCs were cultured on naïve or microtrack-containing MAT in fresh medium or under a gradient of HIC-conditioned medium (Figure 5c ). Quantification data (Figure 5c ) showed that soluble factors secreted by HICs do not promote ELC invasion, further verifying that physical contact between the two cell types is essential to stimulate ELC invasion.
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Conclusion
Intratumor heterogeneity, where a single tumor colony is composed of multiple subpopulations of cancer cells with distinct molecular and gene expression patterns as well as different phenotypic traits, (7) is one of the leading causes of unpredictable drug efficacy and drug resistance (2) . While several studies have been performed to characterize intratumor heterogeneity, the majority are limited to the mechanisms at the molecular and genetic levels, presumably due to the lack of controllable experimental systems that enable precise regulation of cell-cell and cell-ECM interactions in 3D tumor invasion. To our knowledge, the phenotypic characteristics of heterogeneous tumor cell invasion have not been described to date.
In the current study, we established a microfluidic-based tumor heterogeneity in vitro model to determine the phenotypic characteristics, including morphology, and proliferative, invasive, and metastatic potentials, of heterogeneous cell subpopulations in a single tumor colony during tumor progression. Since the ECM within tumors is also heterogeneous, cancer cells need to overcome ECM barriers for successful metastasis (18, 19) . To escape the original tumor mass and invade surrounding tissue, cancer cells display plasticity by employing various strategies, including changes in migration patterns (from collective to single motility) (18, 20) and proteolytic ECM remodeling (21, 22) . In contrast, cancer cells that retain epithelial characteristics mostly grow in place, but to escape from the original tumor colony and metastasize, they need to recruit and allow stromal cells to deposit and remodel ECM (23) or undergo epithelial-mesenchymal transition (EMT) (24, 25) Integrative Biology
